CommentA strategy to halt leprosy transmission
References (11)
Scientific working group on leprosy, Geneva, Switzerland
Global leprosy situation, 2012
Wkly Epidemiol Rec
(2012)WHO Expert Committee on Leprosy: eighth report. Geneva, Switzerland
- et al.
Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions
Lepr Rev
(2004) - et al.
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial
BMJ
(2008)
There are more references available in the full text version of this article.
Cited by (62)
Unwelcome prevalence of leishmaniasis with several other infectious diseases
2022, International ImmunopharmacologyLeprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme
2021, The Lancet Global HealthMolecular epidemiology of leprosy: An update
2020, Infection, Genetics and EvolutionCitation Excerpt :Untreated, leprosy symptoms progress to irreversible physical disabilities such as blindness and limb deformities. Current leprosy control strategies rely on early diagnosis and prompt treatment to minimize the progressive morbidity of leprosy and hopefully interrupt transmission from clinically active cases (Smith et al., 2014). However, this strategy is still not optimally implemented and 5.4% of the new cases were diagnosed with advanced leprosy disabilities in 2018 for which 90% were found in the global priority countries (WHO, 2019).
The role of trained cadres to find new cases of leprosy with a social learning theory approach in the City of Bima, Indonesia
2024, International Journal of Public Health ScienceEstablishing a standard method for analysing case detection delay in leprosy using a Bayesian modelling approach
2023, Infectious Diseases of PovertySpatial analysis of the epidemiological risk of leprosy in the municipalities of Minas Gerais
2023, PLoS Neglected Tropical Diseases
Copyright © 2014 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.